Kaléo Announces First U.S. Department of Defense Supply Contract for the Rapid Opioid Countermeasure System (ROCS) Antidote for Ultra-Potent Weaponized Opioids Richmond, VA, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Kaléo, a privately held commercial-stage U.S. pharmaceutical company, today announced the execution of the first contract with the U.S. Department of...

Kaléo Announces Executive Appointments and New Government Business Unit Richmond, VA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Kaléo, a fully integrated pharmaceutical company dedicated to inventing, manufacturing, and commercializing life-transforming products for certain...

Minor League Baseball, AUVI-Q® (Epinephrine Injection, USP) Team Up to Keep Fans with Peanut Allergies in the Game ST. PETERSBURG, Fla. and RICHMOND, Va., Aug. 03, 2017 (GLOBE NEWSWIRE) -- It’s hard to imagine a baseball game without peanuts, but in a new collaboration between  Minor League Baseball® (MiLB™) and...